ALLR
Price
$1.62
Change
-$0.07 (-4.14%)
Updated
Jun 3, 01:04 PM (EDT)
Capitalization
26.73M
132 days until earnings call
Intraday BUY SELL Signals
CYPH
Price
$1.26
Change
+$0.07 (+5.88%)
Updated
Jun 3, 01:07 PM (EDT)
Capitalization
127.76M
Intraday BUY SELL Signals
Interact to see
Advertisement

ALLR vs CYPH

Header iconALLR vs CYPH Comparison
Open Charts ALLR vs CYPHBanner chart's image
ALLR vs CYPH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALLR vs. CYPH commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLR is a Hold and CYPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (ALLR: $1.68 vs. CYPH: $1.20)
Brand notoriety: ALLR and CYPH are both not notable
ALLR represents the Biotechnology, while CYPH is part of the Investment Managers industry
Current volume relative to the 65-day Moving Average: ALLR: 79% vs. CYPH: 176%
Market capitalization -- ALLR: $26.73M vs. CYPH: $127.76M
ALLR [@Biotechnology] is valued at $26.73M. CYPH’s [@Investment Managers] market capitalization is $127.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The market cap for tickers in the [@Investment Managers] industry ranges from $158.45B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B. The average market capitalization across the [@Investment Managers] industry is $9.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLR’s FA Score shows that 1 FA rating(s) are green whileCYPH’s FA Score has 1 green FA rating(s).

  • ALLR’s FA Score: 1 green, 4 red.
  • CYPH’s FA Score: 1 green, 4 red.
According to our system of comparison, ALLR is a better buy in the long-term than CYPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLR’s TA Score shows that 4 TA indicator(s) are bullish while CYPH’s TA Score has 4 bullish TA indicator(s).

  • ALLR’s TA Score: 4 bullish, 4 bearish.
  • CYPH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALLR is a better buy in the short-term than CYPH.

Price Growth

ALLR (@Biotechnology) experienced а -0.30% price change this week, while CYPH (@Investment Managers) price change was +3.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.03%. For the same industry, the average monthly price growth was -2.51%, and the average quarterly price growth was +2.77%.

The average weekly price growth across all stocks in the @Investment Managers industry was -1.93%. For the same industry, the average monthly price growth was -3.44%, and the average quarterly price growth was -7.86%.

Reported Earning Dates

ALLR is expected to report earnings on Oct 13, 2026.

Industries' Descriptions

@Biotechnology (-2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Investment Managers (-1.93% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYPH($128M) has a higher market cap than ALLR($26.7M). CYPH has higher P/E ratio than ALLR: CYPH (17.07) vs ALLR (0.12). ALLR YTD gains are higher at: 55.556 vs. CYPH (3.448). ALLR has higher annual earnings (EBITDA): -15.11M vs. CYPH (-53.8M). ALLR has more cash in the bank: 16.9M vs. CYPH (9.69M). CYPH has less debt than ALLR: CYPH (38K) vs ALLR (1.39M). ALLR (0) and CYPH (0) have equivalent revenues.
ALLRCYPHALLR / CYPH
Capitalization26.7M128M21%
EBITDA-15.11M-53.8M28%
Gain YTD55.5563.4481,611%
P/E Ratio0.1217.071%
Revenue00-
Total Cash16.9M9.69M174%
Total Debt1.39M38K3,658%
FUNDAMENTALS RATINGS
CYPH: Fundamental Ratings
CYPH
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLRCYPH
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 6 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ALLR
Daily Signal:
Gain/Loss:
CYPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRT2.130.06
+2.90%
PermRock Royalty Trust Trust
ABCB84.631.44
+1.73%
Ameris Bancorp
PRA23.980.15
+0.63%
ProAssurance Corp
SITC4.930.03
+0.61%
SITE Centers Corp
CMCSA24.85-0.20
-0.80%
Comcast Corp

ALLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLR has been closely correlated with TAOX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALLR jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLR
1D Price
Change %
ALLR100%
-2.33%
TAOX - ALLR
87%
Closely correlated
-4.51%
NCNA - ALLR
86%
Closely correlated
-4.61%
NRXP - ALLR
81%
Closely correlated
N/A
ACRV - ALLR
48%
Loosely correlated
+1.28%
BCTX - ALLR
34%
Loosely correlated
-1.21%
More

CYPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYPH has been loosely correlated with INKT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CYPH jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYPH
1D Price
Change %
CYPH100%
+14.29%
INKT - CYPH
42%
Loosely correlated
-3.11%
AXON - CYPH
40%
Loosely correlated
+2.78%
SABS - CYPH
36%
Loosely correlated
+2.03%
AMRN - CYPH
35%
Loosely correlated
+1.25%
ALLR - CYPH
30%
Poorly correlated
-2.33%
More